Published in Blood Weekly, December 15th, 1997
Researcher B. Kallinowski and colleagues found that only one-third of the orthotopic liver transplant (OLT) candidates given accelerated schedules of hepatitis B vaccine with standard dosages developed protective antibodies.
Kallinowski et al. presented the results of this study at the 48th Annual Meeting of the American Association for the Study of Liver Diseases, held November 7-11, 1997...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.